Tag: COVID-19
-
India poised to transform manufacture Roadmap to give China Competition
Keeping imports at bay and moving ahead with the thought of self reliance, India is planning to boost the manufacturing of certain products. In a virtual conference, minister of MSME, Nitin Gatkari said that India is set to move towards production linked incentives for manufacturing of electronics, medical devices and pharmaceutical products while putting restrictions ... -
Indian Government considers reducing 5-year gratuity tenure to a shorter duration
Indian government is considering reducing the five-year gratuity period to a shorter duration as many labour market experts highlighted that five years maturity limit is outdated and doesn’t sever the purpose of current employees needs. The government is contemplating over shortening the period to somewhere between one to three years. The change in employment market, ... -
Guwahati Provides Personal Care To Self Quarantined Covid-19 Patients
In a bid to control the spread of the novel corona virus, state government of Guwahati has decided to give away free pulse- oximeters and a first line of supportive medical aid to all those patients who have decided to stay indoors and observe the 15-day quarantine guideline. The state government has also announced that ... -
Modi Government Pushes For Coal Over Forest Wipe
India’s forests in Chattisgarh are facing the danger of losing their self as Narendra Modi government moves ahead to wipe them out. The Hasdeo Arand 420,000 acres of forest in the central Indian state of Chhattisgarh, it is confirmed is sitting above an estimated 5 billion tonnes of coal. There are efforts being made to ... -
Sun Pharma to provide affordable Medicine for Covid-19 patients
India is seeing an increasing use of the medicines like Favipiravir, along with another antiviral, remdesivir by hospitals in the tackling of the Covid-19 virus. Looking at the increasing number of cases per day, Sun Pharmaceutical Industries is now coming out with its own version of Favipiravir called FluGuard that is to cost Rs. 35 ... -
Health Ministry: Covid-19 vaccine would take more time to reach victims, three in trials
On Tuesday, Union Health Ministry secretary Rajesh Bhushan, while briefing media over the country Covid-19 situation and development of its vaccine said no particular drug that treats corona-virus has been made so far. As per the government sources three vaccines are in trail phase but would take time to be ready for the corona victims. ... -
BCCI issues SOP for players, signed consent needed before training is resumed
On Sunday, BCCI (Board of Control for Cricket in India) issued the SOPs (standard operating procedures) to all the state associations regarding resumption of cricket. These SOPSs are going to aid the state associations and authorities to restart the activities related to cricket. But the players are required to sign the consent forms before they ... -
6 point mantras: Center urges surge states to follow Covid-19 lessons
In a high profile virtual meeting on Friday that went on for three hours, Center has relayed six main pointers to the nine states with highest number of positive Covid-19 cases and are still experiencing daily spikes. The included states are Bihar, Telangana, West Bengal, Andhra Pradesh, Odisha, Karnataka, Jharkhand, Assam and Uttar Pradesh. Center ... -
Delhi Airport mandates 7-day quarantine for international passengers
The Indian government has intensified its efforts to contain the spread of Coronavirus infections across the country. Boosting the efforts to tackle COVID-19 transmission, the Delhi Airport Authority recently issued updated guidelines for international passengers arriving in the national capital. According to the latest guidelines, passengers arriving in Delhi through international flights will have to ... -
Serum Institute To Produce Oxford University Invented Covid-19 Vaccine Doses For Low Income Countries
As the race across nations intensifies to come up with a vaccine to the Covid-19 virus, India is now moving ahead with its plans to give quick approvals to the Serum Institute of India that is now reaching its Phase 3 of vaccine trials. On trial is the promising Covid-19 vaccine that has been developed ...